title: Oxidative burst response to monosodium urate crystals in patients with Behçet's syndrome.
abstract: OBJECTIVE
  An erythematous response to intradermal injection of monosodium urate crystals (MSU) has been demonstrated in Behçet's syndrome (BS). To further elucidate the pathogenesis of this response, the effects of MSU on in vitro oxidative burst reaction of neutrophils and monocytes were investigated.
  
  
  METHODS
  Peripheral blood mononuclear cells from patients with Behçet's syndrome (BS), rheumatoid arthritis (RA), familial Mediterranean fever (FMF) and healthy controls (HC) were incubated with 100 ng/ml phorbol myristate acetate (PMA) and MSU at different dosages (25-500 microg/ml). Oxidative burst reaction was evaluated in neutrophils and monocytes by flow cytometry.
  
  
  RESULTS
  In patients with BS, oxidative burst of neutrophils was significantly increased compared to HC at 125 microg/ml and 250 microg/ml dosages of MSU (p < or = 0.001 and 0.004 respectively). In patients with FMF; there was also an increased oxidative burst reaction at 75 microg/ml, 250 g/ml and 500 microg/ml (p < or = 0.007; 0.001 and 0.004 respectively). In patients with BS, oxidative burst of monocytes was increased only at 125 g/ml dosage of MSU (p < or = 0.002). However, in patients with FMF monocyte burst response was increased at 25 microg/ml, 75 microg/ml and 125 g/ml (p < or = 0.004; < 0.0001; < 0.0001 and 0.002 respectively). In RA group, stimulation with PMA resulted in a higher oxidative burst reaction than FMF and BS (p < or = 0.000 and p < or = 0.008). No correlation was observed between oxidative burst of neutrophils or monocytes and intradermal responses to MSU crystals.
  
  
  CONCLUSIONS
  Oxidative burst reaction with MSU is augmented in neutrophils and monocytes of BS. However, the response is not specific and is unassociated with skin dermal test which has a high specificity for BS.
authors.affiliation: Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Gazi Medical Faculty, Ankara, Turkey. mtalat@ttnet.net.tr
authors.forename: F
authors.initials: F
authors.lastname: Gogus
authors.forename: I
authors.initials: I
authors.lastname: Fresko
authors.forename: Y
authors.initials: Y
authors.lastname: Elbir
authors.forename: E
authors.initials: E
authors.lastname: Eksioglu-Demiralp
authors.forename: H
authors.initials: H
authors.lastname: Direskeneli
mesh_terms: D000328:Adult; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000175:diagnosis; D001528:Behcet Syndrome / Q000097:blood* / Q000175:diagnosis; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D010505:Familial Mediterranean Fever / Q000097:blood / Q000175:diagnosis; D005260:Female; D006801:Humans; D007271:Injections, Intradermal; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000378:metabolism; D008297:Male; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism; D016897:Respiratory Burst / Q000187:drug effects*; D012882:Skin Tests; D014527:Uric Acid / Q000494:pharmacology*
chemical_list: D014527:Uric Acid